NCT01569763View on ClinicalTrials.gov

Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation

NACompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

March 2, 2018

Conditions
Menorrhagia
Interventions
DEVICE

Aurora Endometrial Ablation

Endometrial Ablation using the Aurora Endometrial Ablation system

DEVICE

Rollerball Ablation/Resection

Hysteroscopic rollerball resection/ablation

Trial Locations (13)

37203

Tennessee Women's Care PC, Nashville

47630

Basinski, LLC, Newburgh

55435

Minnesota Gynecology and Surgery, Edina

63141

Mercy Clinic Minimally Invasive Gynecology, St Louis

64460

Hospital Universitario, UANL, Monterrey

67226

Cypress Medical Research Center, LLC, Wichita

76104

Baylor Research Institute, Fort Worth

85015

Women's Health Research, Phoenix

85224

New Horizons Women's Care, Chandler

L8N3Z5

McMaster University/Hamilton Health Sciences, Hamilton

G1W 2J5

La Cite Medicale, Québec

H8P 1C1

Hôpital LaSalle, Ville Lassalle

S4S 6X3

Regina Qu'Appelle Health Region, Regina

Sponsors
All Listed Sponsors
lead

Minerva Surgical, Inc.

INDUSTRY

NCT01569763 - Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation | Biotech Hunter | Biotech Hunter